A detailed history of Bok Financial Private Wealth, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Bok Financial Private Wealth, Inc. holds 110 shares of LLY stock, worth $87,523. This represents 0.01% of its overall portfolio holdings.

Number of Shares
110
Previous 110 -0.0%
Holding current value
$87,523
Previous $99,000 2.02%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $10,873 - $13,635
15 Added 15.79%
110 $99,000
Q2 2023

Aug 08, 2023

SELL
$350.74 - $468.98 $1,753 - $2,344
-5 Reduced 5.0%
95 $44,000
Q1 2023

Apr 21, 2023

BUY
$310.63 - $364.82 $1,553 - $1,824
5 Added 5.26%
100 $34,000
Q3 2022

Nov 07, 2022

BUY
$296.48 - $337.87 $28,165 - $32,097
95 New
95 $31,000
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $1.15 Million - $1.36 Million
-4,143 Reduced 97.76%
95 $31,000
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $141,987 - $176,454
-605 Reduced 12.49%
4,238 $1.21 Million
Q4 2021

Feb 15, 2022

BUY
$224.85 - $279.04 $108,602 - $134,776
483 Added 11.08%
4,843 $1.34 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $966,176 - $1.19 Million
4,360 New
4,360 $1.01 Million
Q3 2021

Nov 09, 2021

SELL
$221.6 - $272.71 $854,932 - $1.05 Million
-3,858 Closed
0 $0
Q2 2021

Aug 03, 2021

BUY
$180.55 - $233.54 $138,301 - $178,891
766 Added 24.77%
3,858 $886,000
Q1 2021

May 12, 2021

BUY
$164.32 - $212.72 $33,849 - $43,820
206 Added 7.14%
3,092 $578,000
Q4 2020

Feb 01, 2021

BUY
$130.46 - $172.63 $188,123 - $248,932
1,442 Added 99.86%
2,886 $487,000
Q3 2020

Nov 06, 2020

SELL
$146.22 - $169.13 $8,334 - $9,640
-57 Reduced 3.8%
1,444 $214,000
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $204,766 - $246,434
1,501 New
1,501 $246,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bok Financial Private Wealth, Inc. Portfolio

Follow Bok Financial Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bok Financial Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bok Financial Private Wealth, Inc. with notifications on news.